• DUVELISIB CHEMBL3039502 Antineoplastic

    Alternate Names:

    Duvelisib
    INK-1197
    INK-1147
    IPI-145
    INK-1197|||IPI-145|||8-CHLORO-2-PHENYL-3-[(1S)-1-(7H-PURIN-6-YLAMINO)ETHYL]ISOQUINOLIN-1-ONE
    8-CHLORO-2-PHENYL-3-((1S)-1-(7H-PURIN-6-YLAMINO)ETHYL)ISOQUINOLIN-1(2H)-ONE
    1(2H)-ISOQUINOLINONE, 8-CHLORO-2-PHENYL-3-((1S)-1-(9H-PURIN-6-YLAMINO)ETHYL)-
    (S)-3-(1-(7H-PURIN-6-YLAMINO)ETHYL)-8-CHLORO-2-PHENYLISOQUINOLIN-1(2H)-ONE
    S7028,INK1197,1201438-56-3
    W-5592
    D10555
    X5816
    ST24036081
    AJ-128213
    AB0032504
    QC-10232
    KB-77917
    HY-17044
    COMPOUND 4904 [PATENT US8193182]
    BC600328
    AK145604
    CS-0888
    IPI-145; INK-1197
    AKOS022186370
    ZINC88346058
    IN2292
    INK 1197
    AOB87713
    SJVQHLPISAIATJ-ZDUSSCGKSA-N
    MOLPORT-028-600-025
    SYN1175
    INK1197
    GTPL7795
    SCHEMBL153543
    DUVELISIB [USAN:INN]
    DUVELISIB (USAN/INN)
    (S)-3-(1-(9H-PURIN-6-YLAMINO)ETHYL)-8-CHLORO-2-PHENYLISOQUINOLIN-1(2H)-ONE
    C22H17CLN6O
    IPI-145 (INK1197)
    610V23S0JI
    IPI 145
    IPI145
    UNII-610V23S0JI
    (S)-3-(1-((9H-PURIN-6-YL)AMINO)ETHYL)-8-CHLORO-2-PHENYLISOQUINOLIN-1(2H)-ONE
    1201438-56-3
    50905713
    223366126
    7795

    Drug Info:

    (0 More Sources)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction PI3-kinase p110-delta subunit inhibitor
    Direct Interaction yes
    Specific Action of the Ligand Inhibition

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Indication/Tumor Type chronic lymphocytic leukemia
    Response Type predicted – sensitive
    Approval Status Phase I

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    AB0032504 Drug Synonym
    DUVELISIB pubchem_primary_name
    50905713 PubChem CID

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DUVELISIB GuideToPharmacology Ligand Name
    223366126 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications: